Abstract  Description  Claims  Drawing  Search report  Cited references 

US61829064   [0001] 

Protective Groups in Organic Chemistry   [0155] 
Compendium of Synthetic Organic Methods   [0155] 
Pharmaceutical Salts   [0186] 
Resolution of inflammation: the beginning programs the end   [0286] 
A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution   [0286] 
Anti-inflammatory therapy in chronic disease: challenges and opportunities   [0286] 
The resolution of inflammation   [0286] 
Role of basic science in the development of new medicines: examples from the eicosanoid field   [0286] 
Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation   [0286] 
Infection regulates pro-resolving mediators that lower antibiotic requirements   [0286] 
Inhibition of prostaglandin biosynthesis   [0286] 
Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution   [0286] 
Fatty acids and inflammation: the cutting edge between food and pharma   [0286] 
Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo   [0286] 
n-3 fatty acids in cardiovascular disease   [0286] 
Contributions of neutrophils to resolution of mucosal inflammation   [0286] 
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing   [0286] 
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals   [0286] 
Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain   [0286] 
Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators   [0286] 
Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids   [0286] 
Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS   [0286] 
Resolvins D1, D2, and Other Mediators of Self-Limited Resolution of Inflammation in Human Blood following n-3 Fatty Acid Supplementation   [0286] 
Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium   [0286] 
A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution   [0286] 
Artificial rearing of infant mice leads to n-3 fatty acid deficiency in cardiac, neural and peripheral tissues   [0286] 
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases   [0286] 
Molecular circuits of resolution: formation and actions of resolvins and protectins   [0286] 
The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion   [0286] 
Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis   [0286] 
Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1   [0286] 
Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction   [0286] 
Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study   [0286] 
A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction   [0286] 
Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study   [0286] 
IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment   [0286] 
Resolvins and protectins in inflammation resolution   [0286] 
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions   [0286] 
J Am Coll Cardiol   [0286] 
Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins   [0286] 
Metabolism and biological production of resolvins derived from docosapentaenoic acid (DPAn-6)   [0286] 
Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis   [0286] 
Bifidobacterium breve with alpha-Linolenic Acid and Linoleic Acid Alters Fatty Acid Metabolism in the Maternal Separation Model of Irritable Bowel Syndrome   [0286] 
Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes   [0286]